Armodafinil
Back to searchMolecule Structure
Scientific Name
Armodafinil
Description of the Drug
Armodafinil is a stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06413
http://www.drugbank.ca/drugs/DB06413
Brand Name(s)
Armodafinil, Nuvigil
Company Owner(s)
Apotex Inc, Cephalon Inc, Watson Laboratories Inc, Natco Pharma Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34489 | |
| DrugBank | DB06413 | |
| PubChem: Thomson Pharma | 14824208 | |
| PubChem | 9690109 | |
| LINCS | LSM-45603 | |
| BindingDB | 50336892 | |
| DrugCentral | 4501 | |
| rxnorm | NUVIGIL | ARMODAFINIL |
| PubChem: Drugs of the Future | 12014108 | |
| ChEBI | 77590 | |
| ZINC | ZINC000003831139 |
